Case Count Updated: June 16, 2017
- June 26, 2017: Fact Sheet on Candida auris – Download [PDF – 2 pages]
- June 16, 2017: case count updated to 86
- May 18, 2017: MMWR Notes from the Field on ongoing transmission
- May 12, 2017: New Q&A for patients and family members and healthcare workers
- May 12, 2017: Updated recommendations for Amphotericin B breakpoint and C. auris colonization
Candida auris is an emerging fungus that presents a serious global health threat. Healthcare facilities in several countries have reported that C. auris has caused severe illness in hospitalized patients. Some strains of Candida auris are resistant to all three major classes of antifungal drugs. This type of multidrug resistance has not been seen before in other species of Candida. Also of concern, C. auris can persist on surfaces in healthcare environments and spread between patients in healthcare facilities, unlike most other Candida species. CDC has developed Interim Recommendations to help prevent the spread of C. auris.
CDC encourages all U.S. laboratory staff who identify C. auris strains to notify their state or local public health authorities and CDC at firstname.lastname@example.org.
- Tsay, S., et. al. Ongoing Transmission of Candida auris in Health Care Facilities — United States, June 2016–May 2017. MMWR, 2017, May 18.
- Vallabhaneni, S., et. al. Investigation of the first seven reported U.S. cases of Candida auris, a globally-emerging invasive fungus — United States, May 2013–August 2016 . MMWR, 2016, Nov 4.
- Lockhart, S., et al., Simultaneous emergence of multidrug resistant Candida auris on three continents confirmed by whole genome sequencing and epidemiological analyses. Clinical Infectious Dis, 2016, Oct 20.
- Gaitán, A.C.R., et al. Nosocomial fungemia by Candida auris: First four reported cases in continental Europe. Rev Iberoam Micol, 2017, Jan 25.
- Ben-Ami, R., et al., Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel. Emerg Infect Dis, 2017. 23(2): p.195-203.
- Sherry, L., et al., Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris. Emerg Infect Dis, 2017.23(2): p. 328-31.
- European Centre for Disease Prevention and Control. Candida auris in healthcare settings – Europe – 19 December 2016. Stockholm: ECDC; 2016.
- Mizusawa, M., et al. Can a multi-drug resistant Candida auris be reliably identified in clinical microbiology laboratories? J. Clin. Microbiol, 2016, Nov 23.
- Clancy, C.J., et al. Emergence of Candida auris: an international call-to-arms. Clinical Infectious Dis, 2016, Oct 20.
- Schelenz, S., et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control. 2016 Oct 19; 5:35.
- Calvo, B., et al. First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia. J Infect, 2016. 73(4): p.369-74.
- Candida auris identified in England. Public Health England. 2016, July 1.
- Candida auris: laboratory investigation, management and infection prevention and control. Public Health England. 2016, June 27.
- Emara, M., et al., Candida auris candidemia in Kuwait, 2014. Emerg Infect Dis, 2015. 21(6): p. 1091-2.
- Magobo, R.E., et al., Candida auris-associated candidemia, South Africa. Emerg Infect Dis, 2014. 20(7): p. 1250-1.
- Chowdhary, A., et al., New clonal strain of Candida auris, Delhi, India. Emerg Infect Dis, 2013. 19(10): p. 1670-3.
- Ben-Ami, R., et al., Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection. Antimicrob Agents Chemother, 2012. 56(5): p. 2518-23.
- Lee, W.G., et al., First three reported cases of nosocomial fungemia caused by Candida auris. J Clin Microbiol, 2011. 49(9): p. 3139-42.
- Satoh, K., et al., Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol, 2009. 53(1): p. 41-4.
- Page last reviewed: November 4, 2016
- Page last updated: June 26, 2017
- Content source: